Who owns Nektar Therapeutics?
- CUSIP Number: 640268108
Tip: Access positions for across all investors
Analyze quarterly positions in Nektar Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Nektar Therapeutics stock
Who bought or sold Nektar Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| EverSource Wealth Advisors | 111.00 | $8.0k | 1% | Mar 2026 |
|
| Hollencrest Securities | 60.00 | $4.3k | 100% | Mar 2026 |
|
| Fortitude Family Office | 7.00 | $504.000000 | -67% | Mar 2026 |
|
| Twin Peaks Wealth Advisors | 5.00 | $384.000000 | 100% | Mar 2026 |
|
| LRI Investments | 1.00 | $72.000000 | 0% | Mar 2026 |
|
| Huntington National Bank | 1.00 | $1.000000 | 0% | Dec 2025 |
|
| Root Financial Partners | 1.00 | $72.000000 | 100% | Mar 2026 |
|
| Farther Finance Advisors | 1.00 | $76.000000 | -99% | Mar 2026 |
|
Who sold out of Nektar Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| 49 Wealth Management | Dec 2025 | 5.4k | $230k |
| Parallel Advisors | Dec 2025 | 1.1k | $45k |
| Nova Wealth Management | Dec 2025 | 40.00 | $1.7k |